You might also read
Articles linked to this work by shared authors, journal, and citation graph.
1The First Hospital of China Medical University, No. 155, St Nanjingbei, Dist Heping, Shenyang, 110001, Liaoning, People's Republic of China, xiaoliangcmu@163.com.
This study proposes using batimastat nanoparticles with transarterial chemoembolization (TACE) to reduce hepatocellular carcinoma (HCC) recurrence and metastasis by inhibiting angiogenesis and tumor cell migration.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: